Targets and patented drugs for chemotherapy of Chagas disease in the last 15 years-period
VG Duschak - Recent patents on anti-infective drug discovery, 2016 - ingentaconnect.com
Background: The American trypanosomiasis, Chagas disease, is a parasitic infection
typically spread by triatomine vectors affecting millions of people all over Latin America …
typically spread by triatomine vectors affecting millions of people all over Latin America …
In Vitro and In Vivo Activities of 2,3-Diarylsubstituted Quinoxaline Derivatives against Leishmania amazonensis
V Kaplum, J Cogo, DP Sangi… - Antimicrobial Agents …, 2016 - Am Soc Microbiol
Leishmaniasis is endemic in 98 countries and territories worldwide. The therapies available
for leishmaniasis have serious side effects, thus prompting the search for new therapies. The …
for leishmaniasis have serious side effects, thus prompting the search for new therapies. The …
Dibenzylideneacetones are potent trypanocidal compounds that affect the Trypanosoma cruzi redox system
D Lazarin-Bidóia, VC Desoti, SC Martins… - Antimicrobial Agents …, 2016 - Am Soc Microbiol
Despite ongoing efforts, the available treatments for Chagas' disease are still unsatisfactory,
especially in the chronic phase of the disease. Our previous study reported the strong …
especially in the chronic phase of the disease. Our previous study reported the strong …
[HTML][HTML] 1, 3, 4-Thiadiazole derivatives of R-(+)-limonene benzaldehyde-thiosemicarbazones cause death in Trypanosoma cruzi through oxidative stress
SC Martins, D Lazarin-Bidóia, VC Desoti… - Microbes and …, 2016 - Elsevier
This work evaluated the in vitro and in vivo activity of TDZ 2 on Trypanosoma cruzi
amastigotes and determined the possible mechanism of action of this compound on T. cruzi …
amastigotes and determined the possible mechanism of action of this compound on T. cruzi …
[HTML][HTML] C5 induces different cell death pathways in promastigotes of Leishmania amazonensis
EA Mendes, VC Desoti, S de Oliveira Silva… - Chemico-Biological …, 2016 - Elsevier
Leishmaniasis is a neglected infection that is caused by Leishmania protozoa, affecting
millions of people worldwide, mainly in tropical and subtropical regions. This disease has …
millions of people worldwide, mainly in tropical and subtropical regions. This disease has …
Clomipramine kills Trypanosoma brucei by apoptosis
JH de Silva Rodrigues, J Stein, M Strauss… - International Journal of …, 2016 - Elsevier
Drug repositioning, ie. use of existing medicals to treat a different illness, is especially
rewarding for neglected tropical diseases (NTD), since in this field the pharmaceutical …
rewarding for neglected tropical diseases (NTD), since in this field the pharmaceutical …
Contribution of natural products to drug discovery in tropical diseases
F Annang, O Genilloud, F Vicente - Comprehensive Analysis of …, 2016 - Wiley Online Library
Summary Malaria, human African trypanosomiasis, Chagas and leishmaniasis are four
protozoan tropical infectious diseases that remain a global public health problem with …
protozoan tropical infectious diseases that remain a global public health problem with …
[PDF][PDF] Research Article Eupomatenoid-5 Isolated from Leaves of Piper regnellii Induces Apoptosis in Leishmania amazonensis
FP Garcia, D Lazarin-Bidóia, T Ueda-Nakamura… - academia.edu
Leishmania spp. are protozoa responsible for leishmaniasis, a neglected disease that kills
up to 50,000 people every year. Current therapies mainly rely on antimonial drugs that are …
up to 50,000 people every year. Current therapies mainly rely on antimonial drugs that are …
Atividade da 2'-hidroxiflavanona em Leishmania amazonensis sensível e resistente ao antimônio e sua associação com fármacos de referência para o tratamento da …
LGF Oliveira - 2016 - arca.fiocruz.br
A leishmaniose é uma doença que merece atenção, devido à grande variedade de
manifestações clínicas associadas e a sua elevada incidência anual. A pesquisa de novos …
manifestações clínicas associadas e a sua elevada incidência anual. A pesquisa de novos …